ShareHub

Viral Video Original Season 1: Discover the best episodes to watch now. Top viral clips, trending moments, and must-see highlights! The post Viral Video Orig...

Inter Miami star Lionel Messi scores milestone 900th goal, joining Ronaldo

Lionel Messi joins Cristiano Ronaldo in the 900-goal club as Nashville eliminates Miami from CONCACAF Champions Cup.

The Iran war is causing a global energy crisis - can China withstand it?

With oil supply disrupted, Beijing's oil reserves and renewable energy push are being put to the test.

Building a global engineering team (plus AI agents) with Netlify - Stack OverflowOvercast

Dana Lawson, CTO of Netlify, shares her insights on leading a lean, globally distributed engineering team that powers 5% of the internet.

Building a global engineering team (plus AI agents) with Netlify - Stack OverflowOvercast

Dana Lawson, CTO of Netlify, shares her insights on leading a lean, globally distributed engineering team that powers 5% of the internet.

I quit my 6-figure banking job and opened a chicken farm in the Philippines

Andrew Fletcher quit his corporate banking job in Canada and moved to the Philippines to start something of his own.

Labubu's wide, toothy grin is coming to the silver screen

Fans can look forward to a "live‑action and CGI hybrid" Labubu movie, produced by big-name Hollywood talent.

Sarah Michelle Gellar says one detail at home has helped her marriage last 23 years

Sarah Michelle Gellar says this setup "stops a lot of petty fighting" in her marriage to Freddie Prinze Jr.

The president said the U.S. “knew nothing” about the Israeli strike on Iran’s gas fields, which triggered Tehran's retaliatory attacks on Qatar's LNG facilit...

Forget AI Stocks: This Potentially Disruptive Biotech Could Soar By 181%, According to Wall Street | The Motley Fool

This stock could make you a fortune in the next two years, or lose you a whole lot of money.

AI is a valuable tool that could unlock significant value for these healthcare leaders and their shareholders.

Hims & Hers Stock Pops 40%: Everything You Need to Know | The Motley Fool

Hims & Hers shares are up over 40% on Monday after announcing a deal with Novo Nordisk.

The price of the company's popular GLP-1 drugs could come down by as much as 50% next year.

Hims & Hers stock traded more than 40% higher after the deal was announced.

Eli Lilly's stock is a bit expensive, even with a bit of a decline this year.

The company incurred a loss in its most recent quarterly results.

Investors were clearly impressed by the medical device specialist's fourth-quarter performance.

On March 9, 2026, a new Novo Nordisk pact reshaped this telehealth player’s GLP-1 strategy, margins, and legal risk profile.

A handful of the industry's income-generating gems are hiding in plain sight.

Evommune has two autoimmune disorder treatments with blockbuster potential.

Why BioNTech Stock Is Getting Crushed Today | The Motley Fool

Nothing about the recent past, present, or foreseeable future seems all that compelling.

2 Healthcare Stocks That Are Too Cheap to Ignore | The Motley Fool

These companies' shares have fallen too far, offering investors an attractive opportunity.

These biotechs are slowly making a name for themselves.

ResMed is a leader in CPAP machines and other medical devices that help millions breathe better.

Current shareholders were thrown an unexpected curveball that they actually should have been expecting.

They are down, but they are not out.